Dual inhibitor of receptor tyrosine kinases (RTKs) (IC50
< 0.02 μ
M for Abl, Src, VEGFR-2 and PDGFR) and PI 3-K family kinases (IC50
< 0.06 μ
M for p110α
, DNA-PK and mTOR). Exhibits no significant effect on receptor serine/threonine kinases (RSTKs). Blocks the proliferation of tumor cells by direct inhibition of PI 3-K, mTOR, Src and the VEGF receptor.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.
Apsel et al.